When Health Care is Unjust

A confessed killer who damaged his liver in a botched suicide attempt was given a transplant ahead of a cancer sufferer who has been waiting for more than a year for an organ, the New York Post reported Monday.

New York City resident Kerry Sullivan, 53, must wait for a cadaver liver from an elderly donor or find his own living donor, while Johnny Concepcion, 42, got a transplant days after he confessed to fatally stabbing his wife and downing rat poison in a suicide attempt that destroyed his liver.

"It's a waste of an organ," Sullivan said. "It's ludicrous. Not only did they give it to a killer, but a suicidal killer. How this guy can get priority, with all the thousands of people waiting, is outrageous."

As of mid-July, 50 New York liver-transplant candidates died this year waiting for an organ, according to the Organ Procurement and Transplant Network.

"It's extremely frustrating, and it's scary to know that I could die before I find a donor," Sullivan said. "My wait is excruciating — as it is for everyone out there waiting."

I know - this case is not exactly related to lymphoma, but the issue is connected. With limited - finite - resources, how do we decide who is more worthy? And who should decide?

It's also a reminder to me that even with cases like this which appear to be unjust, being an organ donor is still valuable. Even cancer patients can often become donors if they wish.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap